NASH/NAFLD management
James, O.F.W.
Acta Gastro-Enterologica Belgica 65(4): 200-203
2002
ISSN/ISBN: 1784-3227 PMID: 12619426 Document Number: 540604
Document emailed within 1 workday
Related Documents
Miyake, T.; Onji, M. 2012: Nafld, Nash Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 5): 528-532Aoyama, T.; Watanabe, S. 2016: Liver disease (NAFLD, NASH) Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 460-464
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Tanaka, N.; Aoyama, T. 2006: PPAR and NASH Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1089-1094
Tokushige, K. 2009: Diagnosis and therapy in NASH Rinsho Byori. Japanese Journal of Clinical Pathology 57(9): 848-853
Hagström, H.; Hoffstedt, J.; Reynisdottir, S. 2017: New guidelines for NAFLD – a Swedish perspective Lakartidningen 114
Fagoonee, S.; Pellicano, R. 2014: Vitamin D and NAFLD: the need for interventional trials Minerva Medica 105(3): 261
Rastamanesh, R.; Catanzaro, R.; Sollano, Jè.; Marotta, F. 2014: NAFLD: a sign of "early aging"? Acta Bio-Medica: Atenei Parmensis 84(3): 244-245
Reyes, Rúl.Bernal. 2006: NAFLD and metabolic syndrome a troublesome association Revista de Gastroenterologia de Mexico 71(4): 510-511
Morita, Y.; Ueno, T.; Sasaki, N.; Tateishi, Y.; Nagata, E.; Kage, M.; Sata, M. 2005: Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes Hepato-Gastroenterology 52(65): 1338-1343
Joyner, D. 2004: Nash County Emergency Services offers Explorer program Emergency Medical Services 33(7): 67
P, S.; Nh, R. 2020: Study of Correlation between Carotid Intimalthickness and Insulin Resistance in Patients with NAFLD Journal of the Association of Physicians of India 68(1): 88
Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681
Lazarus, J.V.; Mark, H.E.; Colombo, M.; Demaio, S.; Dillon, J.F.; George, J.; Hagström, H.; Hocking, S.; Lee, N.; Nieuwenhuijsen, M.J.; Rinella, M.E.; Romero-Gomez, M.; Soriano, J.B.; Schattenberg, J.ör.M.; Tacke, F.; Tsochatzis, E.A.; Valenti, L.; Zelber-Sagi, S.; Ashworth Dirac, M.; Huang, T.T.-K. 2022: A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach Alimentary Pharmacology and Therapeutics 55(2): 234-243
Lesmana, C.R.; Lesmana, L.A.; Akbar, N.; Gani, R.A.; Simandjuntak, W.; Oemardi, M.; Soejono, C.H.; Marwoto, W.; Juwono, V. 2009: Clinical picture, insulin resistance, and adipocytokines profiles of nonalcoholic steatohepatitis (NASH) patients in Indonesia Acta Medica Indonesiana 41(1): 6-10
Spolaore, P.; Murolo, G.; Sommavilla, M. 2003: Medical record management and risk management processes. State of the art and new normative guidelines about the organization and the management of the sanitary documentation in the National Health System or Hospital Trusts Annali di Igiene: Medicina Preventiva e di Comunita 15(6): 805-815
Contzen, H. 1979: Open injuries (initial management and continued therapy). Initial management of open injuries at the accident site (emergency management and transportation problems) Hefte Zur Unfallheilkunde 138: 23-25
Schöbel, M.; Stäubert, S.; Löbe, M.; Meinel, K.; Winter, A. 2016: Requirements on Clinical Trial Management Systems for Academic Site Management Organizations Studies in Health Technology and Informatics 228: 292-296
Sahney, V.K. 1993: Evolution of hospital industrial engineering: from scientific management to total quality management Journal of the Society for Health Systems 4(1): 3-17